Veeva Systems Inc. (VEEV) News

Veeva Systems Inc. (VEEV)

Today's Latest Price: $284.68 USD

2.59 (-0.90%)

Updated Oct 29 6:40pm

Add VEEV to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 70 in Medical - Services

See all "A" rated Strong Buy stocks

Filter VEEV News Items

VEEV News Results

Event/Time Symbol Company News Detail Start End Change POWR Rating
Loading, please wait...

Latest VEEV News From Around the Web

Below are the latest news stories about Veeva Systems Inc that investors may wish to consider to help them evaluate VEEV as an investment opportunity.

Cloud Stocks: The Unstoppable Veeva

According to a Markets and Markets report, the global market for healthcare cloud computing is expected to grow from $28.1 billion in 2020 to $64.7 billion by 2025 at a CAGR of 18.1%. Pleasanton, California-based Veeva (VEEV) recently reported its second-quarter results that continued to surpass all market expectations. Veeva's...

Sramana Mitra on Seeking Alpha | October 1, 2020

Global eClinical Solutions Market 2020-2026 Refreshing Trends || Major Giants – Oracle, Medidata Solutions, Inc., Veeva Systems, ERT Clinical, eClinical Solutions LLC, IBM Corporation

DBMR has added a new report titled Global eClinical Solutions Market with analysis provides the insights which bring marketplace clearly into the focus and thus help organizations make better decisions. The data and the information regarding the industry are taken from

OpenPR | September 30, 2020

Veeva Systems: Strong Healthcare CRM Play, But Valuation Is Full

Investment Thesis Veeva Systems (VEEV) is a leading vertical SaaS play focused on providing a core CRM product alongside other life science-focused software tools to a largely pharmaceutical and biotechnology company customer base. The stock has performed well, particularly vs. the S&P, as illustrated below: Data by YCharts The life...

Captain Alpha on Seeking Alpha | September 29, 2020

Veeva partners with RedHill Bio to advance Opaganib in COVID-19 (NASDAQ:RDHL)

Veeva Systems (NYSE:VEEV) and Bioforum collaborates with RedHill Biopharma (NASDAQ:RDHL) on a global Phase 2/3 clinical study evaluating opaganib (Yeliva,

Seeking Alpha | September 23, 2020

Worldwide Risk-based Monitoring Software Industry to 2026 - Featuring MasterControl, Veeva Systems & Techso Among Others -

DUBLIN--(BUSINESS WIRE)--The "Global Risk-based Monitoring Software Market Analysis 2020" report has been added to's offering. The Global Risk-based Monitoring Software market is expected to reach $652.40 million by 2026 growing at a CAGR of 15.3% from 2019 to 2026. Risk-based monitoring (RBM) software is a clinical trial-monitoring method that fulfills regulatory necessities. It employs various tools, platforms and dashboards to identify signals, which indicate potential

Business Wire | September 18, 2020

Veeva Systems Inc. (VEEV) CEO Peter Gassner on Q2 2021 Results - Earnings Call Transcript

Veeva Systems Inc. (VEEV) Q2 2021 Earnings Conference Call August 27, 2020 4:30 P.M. ET Company Participants Rick Lund - Head of Investor Relations Peter Gassner - Founder and Chief Executive Officer Tim Cabral - Chief Financial Officer Paul Shawah - Senior Vice President of Commercial Cloud Conference Call Participants...

SA Transcripts on Seeking Alpha | August 28, 2020

Veeva Systems gains after raising full-year outlook

Veeva Systems (VEEV) shares are up 4% after hours following Q2 beats that included 33% Y/Y revenue growth. Subscription services sales totaled $283.5M (consensus: $276.8M). Professional services sales were $70.2M, above the $63.3M estimate.Operating income was $144.4M, up 39%.For Q3, Veeva forecasts $360-362M in revenue (consensus: $347.4M) and $0.66-0.68 EPS (consensus: $0.64) with operating income...

Seeking Alpha | August 27, 2020

Veeva Systems EPS beats by $0.08, beats on revenue

Veeva Systems (VEEV): Q2 Non-GAAP EPS of $0.72 beats by $0.08; GAAP EPS of $0.58 beats by $0.06.Revenue of $353.68M (+32.5% Y/Y) beats by $13.68M.Revenues from Subscription services of $283.5M beats consensus $276.8M and Professional services and Other of $70.2M beats consensus $63.3M.Adj. operating margin of 40.8% vs consensus 37.4%.Shares...

Seeking Alpha | August 27, 2020

Veeva Systems EPS beats by $0.08, beats on revenue (NYSE:VEEV)

Veeva Systems (NYSE:VEEV): Q2 Non-GAAP EPS of $0.72 beats by $0.08; GAAP EPS of $0.58 beats by $0.06. Revenue of $353.68M (+32.5% Y/Y) beats by $13.68M. Sh

Seeking Alpha | August 27, 2020

S&P 500 on Trend, Nvidia Ahead of Earnings, Tesla Targets, Trading Veeva Systems

S&P 500 on Trend, Huawei, Nvidia Ahead of Earnings, Trading Veeva Systems: Market Recon…AAP

The Street RealMoney | August 18, 2020

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5357 seconds.